Hacker News Reader

Slows down your gut motility, can't wait for the epidemic of new SIBO/IBS cases.

Gastroparesis, and mostly found when on liraglutides (Saxenda),[1] though that hasn't stopped lawsuits against semaglutides.[2]

There's some interest in GLP-1 receptor agonists as IBS _treatments_, specifically for pain relief in IBS-C and IBS-M, though it's way too early to talk about meaningfully.[3][4]

1: https://jamanetwork.com/journals/jama/fullarticle/2810542

2: https://www.nbcnews.com/health/health-news/makers-ozempic-mo...

3: https://pubmed.ncbi.nlm.nih.gov/35234561/

4: https://pubmed.ncbi.nlm.nih.gov/31602785/

Reply on news.ycombinator.com